Evaluation of USP 36 Enzyme Expression in Oral Squamous Cell Carcinoma
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Oral cancer is one of the top three types of cancer in India and is of significant public health importance. A common post translational modification in cells is ubiquitination and deubiquitination. The ubiquitin proteasome pathway is one of the major destruction ways to control the activities of different proteins. Deubiquitinases are involved in removing ubiquitin from ubiquitylated substrates to regulate their activity and stability. They are involved in various cellular functions including proteasome and lysosome dependent proteolysis, gene expression, cell cycle progression, chromosome segregation, kinase activation, histone modification, cell cycle regulation, cell differentiation, spermatogenesis, apoptosis, endocytosis, autophagy, localization, and DNA damage repair. On the other hand, dysregulation of DUBs is involved in the processes of carcinogenesis and cancer development too and are related to different aspects of human cancer, including proliferation, cell cycle control, apoptosis, DNA damage response, tumor suppression, oncogenesis, and metastasis. While there are many studies on dysregulation of DUBs in several human diseases, there is a dearth of studies on the role of DUBs in Oral Squamous Cell Carcinoma. Therefore, the present study was done to evaluate the expression of USP 36 in Oral Squamous cell carcinoma and compared to the control group using RT PCR and Immuno histochemistry. This study has revealed upregulated USP 36 expressions in Oral Squamous Cell Carcinoma, implying correlation of USP 36 with the progression of Oral Squamous cell carcinoma. The findings of this study provide insight on the USP 36 expression in OSCC paving way whether USP 36 can serve as one of the drug targets in therapeutic strategies developed against Oral squamous cell Carcinoma